Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.33 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17546684 | 0.86 | MEN1 (0.61) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| SCHEMBL16556482 | 0.80 | MEN1 (0.54) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| SCHEMBL2386783 | 0.80 | — | — | |
| SCHEMBL17344727 | 0.79 | MEN1 (0.64) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| SCHEMBL25970361 | 0.79 | TSHR (0.56) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| Propanol SCHEMBL28627241 | 0.79 | MEN1 (0.52) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| SCHEMBL27512309 | 0.77 | MEN1 (0.50) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| SCHEMBL20224856 | 0.76 | MEN1 (0.54) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| SCHEMBL23419140 | 0.74 | MEN1 (0.47) | MEN1KMT2ASTAT3HSD17B10MTNR1A | |
| SCHEMBL13367647 | 0.74 | MEN1 (0.47) | MEN1KMT2ASTAT3HSD17B10MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2673000-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | Wu, Nian (US) | 2013-12-18 | — | — | EP | claimed |
| WO-2012109112-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | claimed |
| WO-2012109052-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | claimed |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPOSEUTICALS, INC. | 2012-08-09 | — | — | US | claimed |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-09 | — | — | US | claimed |
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2010-03-25 | — | — | US | claimed |
| EP-3313857-B1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN (US) | 2021-01-06 | — | — | EP | disclosed |
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPOSEUTICALS INC | 2020-11-17 | — | — | US | disclosed |
| EP-3077006-B1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | WU NIAN (US) | 2020-08-19 | — | — | EP | disclosed |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | LIPOSEUTICALS INC | 2018-09-04 | — | — | US | disclosed |
| EP-2673000-B1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2018-05-16 | — | — | EP | disclosed |
| EP-3313857-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | Wu, Nian (US) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016209732-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN (US) | 2016-12-29 | — | — | WO | disclosed |
| EP-2673000-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | Wu, Nian (US) | 2013-12-18 | — | — | EP | disclosed |
| US-8304565-B2 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2012-11-06 | — | — | US | disclosed |
| WO-2012109112-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | disclosed |
| WO-2012109052-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | disclosed |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPOSEUTICALS, INC. | 2012-08-09 | — | — | US | disclosed |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-09 | — | — | US | disclosed |
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | BIOZONE LABORATORIES INC. | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076209-A1 | PEG-lipid conjugates for liposomes and drug delivery | DAGLA, DAGLB, DGKG | MEN1 2105/4885KMT2A 4305/4885STAT3 4135/4885 |
| US-10835608-B2 | Polymer-carbohydrate conjugates for drug delivery technology | LIPC, FABP4, CETP | MEN1 2733/4885KMT2A 1977/4885STAT3 3177/4885 |
| US-10064954-B2 | Polymer-cyclodextrin-lipid conjugates | CETP, FABP4, PLIN3 | MEN1 3960/4885KMT2A 4200/4885STAT3 3683/4885 |
| US-20120202890-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPC, FUT6, UGCG | MEN1 1849/4885KMT2A 1692/4885STAT3 4808/4885 |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPC, FUT6, UGCG | MEN1 1849/4885KMT2A 1692/4885STAT3 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.